Speaker Profile

PhD, CTO, EarlyDiagnostics

Biography
Dr. Ni serves as the Chief Technology Officer at EarlyDx, bringing more than two decades of experience in research and product development to the team, His expertise spans a wide range of disciplines, including physics, molecular biology, and cancer genomics. Before joining EarlyDx, Dr. Ni held a senior scientist at Cynvenio Biosystems, now known as LungLife AI, where he played a pivotal role in the development of Cynvenio's FISH test for early lung cancer detection using circulating tumor cells. Dr. Ni currently leads EarlyDx's NIH SBIR project focused on assay development. He earned his Ph.D. in Physics from the City University of New York and completed his postdoctoral training in SingleCell Cancer Genomics at Harvard University.


Talk
Methylome-Based Liquid Biopsy for Early Detection of Multiple Cancers
EarlyDx's MethylScan technology delivers costeffective cfDNA methylome sequencing, facilitating sensitive and specific detection and localization of various types of cancer.


 Session Abstract – PMWC 2024 Silicon Valley

Track 4 - January 25 9.00 A.M.-4.30 P.M.


Track Chair: Laura J. van 't Veer, UCSF

  • PMWC 2024 Award Ceremony
    Pioneer Honoree: David Sidransky, Johns Hopkins
    Pioneer Honoree: Helmy Eltoukhy
    Pioneer Honoree: AmirAli Talasaz, Guardant Health
  • Utilities of Liquid Biopsy in Biomarker Testing
    - Laura Vent Veer, UCSF
  • Status Quo of Clinical Liquid Biopsy (PANEL)
    Chair: Helmy Eltoukhy, Guardant Health
    - Sadakatsu Ikeda, Tokyo Medical University
    - Heather Parsons, Dana-Farber Cancer Institute
    - Sanjay Popat, The Royal Marsden
  • Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
    Chair: Anne-Renee Hartman, Adela Bio
    - AmirAli Talasaz, Guardant Health
    - Heather Parsons, Dana-Farber Cancer Institute
    - Mary Pat Lancelotta, Adaptive Bio
    - Sylvia Katina Plevritis, Stanford
  • Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing (PANEL)
    Chair: Tom Beer, Exact Sciences
    - Wendy Rubinstein, National Cancer Institute
    - Sheila D. Walcoff, Goldbug Strategies LLC
  • Keynote: Pioneering Liquid Nucleic Acids Tumor Fragments in Health and Diseases
    - David Sidransky, Johns Hopkins
  • New Approaches in Liquid Biopsy (PANEL)
    Chair: Victor Velculescu, Johns Hopkins
    - David Sidransky, Johns Hopkins
    - Dan Laudau, NY Genome Center
    - Daniel De Carvalho, University of Toronto
  • Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
    Chair: Debra Fraser-Howze, D. Fraser Associates
    - Belinda Nedjai, Wolfson Institute of Population Health
    - Elisabeth Adams, Aquarius Population Health Limited
  • NCI Showcase
    - Xiaohui Ni, Early Dx
    - Daniel Kim, UCSC

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUN. 6TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required